Ocular Therapeutix, Inc. (OCUL) stock analysis
OCUL · Ocular Therapeutix, Inc.
Latest recorded price: USD 6.01
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth 0.3%, free cash flow margin -417.5%, ROIC -108.2%. The model flags 2 risk signals for this company (2 high severity).